ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen

Title
ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen
Authors
Keywords
ALK IHC, NSCLC, Immunohistochemistry, External quality assessment
Journal
Journal of Thoracic Oncology
Volume 11, Issue 12, Pages 2241-2247
Publisher
Elsevier BV
Online
2016-07-26
DOI
10.1016/j.jtho.2016.07.012

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now